FDLI Webinar: Ensuring Effective Responses to FDA 483s and Warning Letters

FDLI Webinar: Ensuring Effective Responses to FDA 483s and Warning Letters Hyman, Phelps & McNamara, P.C. Director Kalie E. Richardson will be moderating a Food and Drug Law Institute webinar this coming Wednesday on Ensuring Effective Responses to FDA 483s and Warning Letters. This webinar will cover fundamental considerations for responding to FDA 483s and Warning Letters, discussion of real-world case studies, and actionable strategies to help life sciences companies avoid regulatory escalation. Time will also be reserved for participant questions. The webinar is on Wednesday, January 21 at 12 PM ET and will also be recorded. Registration information is available here: Got Observations?: Ensuring Effective Responses to FDA 483s and Warning Letters. https://www.thefdalawblog.com/2026/01/fdli-webinar-ensuring-effective-responses-to-fda-483s-and-warning-letters/?utm_source=rss&utm_medium=rss&utm_campaign=fdli-webinar-ensuring-effective-responses-to-fda-483s-and-warning-letters Got Observations?: Ensuring Effective Responses to FDA 483s and Warning Letters January 21, 2026 | Live Webinar https://portal.fdli.org/s/lt-event?id=a1URn00000310dlMAA https://www.fdli.org/